[go: up one dir, main page]

AU2003238790A1 - Erbin as a negative regulator of ras-raf-erk signaling - Google Patents

Erbin as a negative regulator of ras-raf-erk signaling

Info

Publication number
AU2003238790A1
AU2003238790A1 AU2003238790A AU2003238790A AU2003238790A1 AU 2003238790 A1 AU2003238790 A1 AU 2003238790A1 AU 2003238790 A AU2003238790 A AU 2003238790A AU 2003238790 A AU2003238790 A AU 2003238790A AU 2003238790 A1 AU2003238790 A1 AU 2003238790A1
Authority
AU
Australia
Prior art keywords
erbin
raf
ras
negative regulator
erk signaling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003238790A
Other languages
English (en)
Other versions
AU2003238790A8 (en
Inventor
Yang Z. Huang
Lin Mei
Wen C. Xiong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Publication of AU2003238790A8 publication Critical patent/AU2003238790A8/xx
Publication of AU2003238790A1 publication Critical patent/AU2003238790A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003238790A 2002-05-29 2003-05-28 Erbin as a negative regulator of ras-raf-erk signaling Abandoned AU2003238790A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38360202P 2002-05-29 2002-05-29
US60/383,602 2002-05-29
PCT/US2003/016884 WO2003102139A2 (fr) 2002-05-29 2003-05-28 Erbine utilisee en tant que regulateur negatif de la signalisation ras-raf-erk

Publications (2)

Publication Number Publication Date
AU2003238790A8 AU2003238790A8 (en) 2003-12-19
AU2003238790A1 true AU2003238790A1 (en) 2003-12-19

Family

ID=29711928

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003238790A Abandoned AU2003238790A1 (en) 2002-05-29 2003-05-28 Erbin as a negative regulator of ras-raf-erk signaling

Country Status (2)

Country Link
AU (1) AU2003238790A1 (fr)
WO (1) WO2003102139A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526285A1 (fr) 2003-05-15 2004-12-23 Arqule, Inc. Inhibiteurs de p38 et leurs methodes d'utilisation
US7829560B2 (en) 2004-07-08 2010-11-09 Arqule, Inc. 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
WO2006044869A1 (fr) 2004-10-19 2006-04-27 Arqule, Inc. Synthese d'inhibiteurs d'imidazo-oxazole et d'imidazothiazole de la map kinase p38
EP2258370A1 (fr) * 2009-06-05 2010-12-08 Medizinische Universität Wien Traitement de maladies malignes
EP2433636A1 (fr) 2010-09-27 2012-03-28 Medizinische Universität Wien Traitement de maladies malignes

Also Published As

Publication number Publication date
AU2003238790A8 (en) 2003-12-19
WO2003102139A2 (fr) 2003-12-11
WO2003102139A3 (fr) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2003210829A1 (en) Battery-powered wristwatch
AU2003274404A1 (en) Artificial transcription factors
AU2003224293A1 (en) Lighting module
AU2003262634A1 (en) Partition mount with extended-length head
AU2002243075A1 (en) A visor
AU2003294702A1 (en) Battery supply for headset system
AU2003235266A1 (en) Thin battery
AU2003242258A1 (en) Battery
AU2003248566A1 (en) Novel anti-infectives
AU2003301183A1 (en) Attachment /detachment tape
AU2003228139A1 (en) Bioreactor
AU2002951307A0 (en) Double-sided irrigator
AU2003238790A1 (en) Erbin as a negative regulator of ras-raf-erk signaling
AUPS334602A0 (en) Glutathione production
AU2002329533A1 (en) Battery holder
AU2003297597A1 (en) Benzimidazoles and analogs thereof as antibacterials
AU2003216663A1 (en) Luminaire
AU2002339262A1 (en) Rigid sail
AU2003235285A1 (en) Battery
AU2002951260A0 (en) Zinc air battery
AU2002311143A1 (en) Helmet
AU2003231207A1 (en) A bryostatin composition
AU2002368450A1 (en) Radioablation of hemolymphopoietic cell populations
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003282635A1 (en) Mounting of a propeller

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase